Jalra 50mg Tablet 15s

Uses of Jalra 50mg Tablet 15s

Vildagliptin is an oral anti diabetic medicine. Vildagliptin is used in the treatment of Type 2 Diabetes . It maintains blood glucose level in diabetic patients .

Side Effects of Jalra 50mg Tablet 15s

Hypoglycaemia, delayed gastric emptying, nausea and vomiting. Flu-like symptoms, headache and dizziness may occur. Potentially Fatal: Stevens-Johnson syndrome.

Drug Interactions

Increased risk of hypoglycaemia when used with other anti-diabetic agents thus dose adjustments may be required.

Mechanism of Action

Vildagliptin is a dipeptidylpeptidase-4 (DPP-4) inhibitor that improves glycaemic control by preventing DPP-4 from inactivating the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, thus prolonging incretin activity in response to ingestion of nutrients. This increases insulin sensitivity, decreases glucagon secretion and improves β-cell function. Absorption: Rapidly absorbed. Max plasma concentrations achieved 1-2 hr after oral admin. Oral bioavailability: About 85%. Metabolism: Metabolised by hydrolysis. Excretion: Mainly excreted in the urine.

Special Precautions

Renal impairment.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

• Alcohol: Avoid during treatment.
• Breastfeeding: Not recommended.
• Pregnancy: Contraindicated.
• Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.